메뉴 건너뛰기




Volumn 49, Issue 15, 2013, Pages 3140-3148

Diffuse malignant peritoneal mesothelioma: Long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)

Author keywords

Cytoreductive surgery; Diffuse malignant peritoneal mesothelioma; HIPEC; Hyperthermic intraperitoneal chemotherapy; Peritoneal surface malignancies; Peritonectomy

Indexed keywords

CALRETININ; CISPLATIN; CYTOKERATIN 5; DOXORUBICIN; GROWTH FACTOR RECEPTOR; MITOMYCIN; PODOPLANIN;

EID: 84884902389     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.05.027     Document Type: Article
Times cited : (119)

References (32)
  • 1
    • 69149105448 scopus 로고    scopus 로고
    • Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the International Mesothelioma Interest Group
    • A.N. Husain, T.V. Colby, and N.G. Ordóñez Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group Arch Pathol Lab Med 133 2009 1317 1331
    • (2009) Arch Pathol Lab Med , vol.133 , pp. 1317-1331
    • Husain, A.N.1    Colby, T.V.2    Ordóñez, N.G.3
  • 2
    • 79955696363 scopus 로고    scopus 로고
    • Diffuse malignant peritoneal mesothelioma: Systematic review of clinical management and biological research
    • D. Baratti, S. Kusamura, and M. Deraco Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research J Surg Oncol 103 2011 822 831
    • (2011) J Surg Oncol , vol.103 , pp. 822-831
    • Baratti, D.1    Kusamura, S.2    Deraco, M.3
  • 3
    • 77951893959 scopus 로고    scopus 로고
    • Malignant peritoneal mesothelioma: A multicenter study on 81 cases
    • V. de Pangher Manzini, L. Recchia, and M. Cafferata Malignant peritoneal mesothelioma: a multicenter study on 81 cases Ann Oncol 21 2010 348 353
    • (2010) Ann Oncol , vol.21 , pp. 348-353
    • De Pangher Manzini, V.1    Recchia, L.2    Cafferata, M.3
  • 4
    • 63449105164 scopus 로고    scopus 로고
    • Malignant peritoneal mesothelioma - Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent
    • G. Carteni, C. Manegold, and G.M. Garcia Malignant peritoneal mesothelioma - results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent Lung Cancer 64 2009 211 218
    • (2009) Lung Cancer , vol.64 , pp. 211-218
    • Carteni, G.1    Manegold, C.2    Garcia, G.M.3
  • 5
    • 49049097151 scopus 로고    scopus 로고
    • Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: Final report of a phase II trial
    • G.R. Simon, C.F. Verschraegen, and P.A. Jänne Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial J Clin Oncol 26 2008 3567 3572
    • (2008) J Clin Oncol , vol.26 , pp. 3567-3572
    • Simon, G.R.1    Verschraegen, C.F.2    Jänne, P.A.3
  • 6
    • 1542648318 scopus 로고    scopus 로고
    • Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy
    • A.L. Feldman, S.K. Libutti, and J.F. Pingpank Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy J Clin Oncol 21 2003 4560 4567
    • (2003) J Clin Oncol , vol.21 , pp. 4560-4567
    • Feldman, A.L.1    Libutti, S.K.2    Pingpank, J.F.3
  • 7
    • 33845631273 scopus 로고    scopus 로고
    • Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma
    • T.D. Yan, E.A. Brun, and C.A. Cerruto Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma Ann Surg Oncol 14 2007 41 49
    • (2007) Ann Surg Oncol , vol.14 , pp. 41-49
    • Yan, T.D.1    Brun, E.A.2    Cerruto, C.A.3
  • 8
    • 37149047839 scopus 로고    scopus 로고
    • Malignant peritoneal mesothelioma: Treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy
    • D. Elias, V. Bedard, and T. Bouzid Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy Gastroenterol Clin Biol 31 2007 784 788
    • (2007) Gastroenterol Clin Biol , vol.31 , pp. 784-788
    • Elias, D.1    Bedard, V.2    Bouzid, T.3
  • 9
    • 74949123203 scopus 로고    scopus 로고
    • Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: Multi-institutional experience
    • T.D. Yan, M. Deraco, and D. Baratti Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience J Clin Oncol 27 2009 6237 6242
    • (2009) J Clin Oncol , vol.27 , pp. 6237-6242
    • Yan, T.D.1    Deraco, M.2    Baratti, D.3
  • 10
    • 74649083292 scopus 로고    scopus 로고
    • Lymph node metastases in diffuse malignant peritoneal mesothelioma
    • D. Baratti, S. Kusamura, and A.D. Cabras Lymph node metastases in diffuse malignant peritoneal mesothelioma Ann Surg Oncol 17 2010 45 53
    • (2010) Ann Surg Oncol , vol.17 , pp. 45-53
    • Baratti, D.1    Kusamura, S.2    Cabras, A.D.3
  • 11
    • 78049463296 scopus 로고    scopus 로고
    • Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: Mitomycin versus cisplatin
    • A.U. Blackham, P. Shen, and J.H. Stewart Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin Ann Surg Oncol 17 2010 2720 2727
    • (2010) Ann Surg Oncol , vol.17 , pp. 2720-2727
    • Blackham, A.U.1    Shen, P.2    Stewart, J.H.3
  • 12
    • 0028797043 scopus 로고
    • Peritonectomy procedures
    • P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1995 29 42
    • (1995) Ann Surg , vol.221 , pp. 29-42
    • Sugarbaker, P.H.1
  • 13
    • 0025020584 scopus 로고
    • Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment
    • G. Los, P.H. Mutsaers, and W.J. Lenglet Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment Cancer Chemother Pharmacol 25 1990 389 394
    • (1990) Cancer Chemother Pharmacol , vol.25 , pp. 389-394
    • Los, G.1    Mutsaers, P.H.2    Lenglet, W.J.3
  • 14
    • 27644476267 scopus 로고    scopus 로고
    • Diffuse malignant mesothelioma of the peritoneum
    • D. Nonaka, S. Kusamura, and D. Baratti Diffuse malignant mesothelioma of the peritoneum Cancer 104 2005 2181 2188
    • (2005) Cancer , vol.104 , pp. 2181-2188
    • Nonaka, D.1    Kusamura, S.2    Baratti, D.3
  • 15
    • 0029914456 scopus 로고    scopus 로고
    • Current methodologies for clinical assessment of patients with peritoneal carcinomatosis
    • P. Jaquet, and P.H. Sugarbaker Current methodologies for clinical assessment of patients with peritoneal carcinomatosis J Exp Clin Cancer Res 15 1996 49 58
    • (1996) J Exp Clin Cancer Res , vol.15 , pp. 49-58
    • Jaquet, P.1    Sugarbaker, P.H.2
  • 16
    • 31544444216 scopus 로고    scopus 로고
    • Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion
    • M. Deraco, D. Nonaka, and D. Baratti Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion Ann Surg Oncol 13 2006 229 237
    • (2006) Ann Surg Oncol , vol.13 , pp. 229-237
    • Deraco, M.1    Nonaka, D.2    Baratti, D.3
  • 17
    • 84862564957 scopus 로고    scopus 로고
    • Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: A controlled study
    • [epub ahead of print]
    • D. Baratti, S. Kusamura, A.D. Cabras, and M. Deraco Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study Ann Surg Oncol 2012 [epub ahead of print]
    • (2012) Ann Surg Oncol
    • Baratti, D.1    Kusamura, S.2    Cabras, A.D.3    Deraco, M.4
  • 18
    • 0037080101 scopus 로고    scopus 로고
    • Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: Phase i study
    • C.R. Rossi, M. Foletto, and S. Mocellin Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study Cancer 94 2002 492 499
    • (2002) Cancer , vol.94 , pp. 492-499
    • Rossi, C.R.1    Foletto, M.2    Mocellin, S.3
  • 19
    • 75049085762 scopus 로고    scopus 로고
    • Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma
    • T.C. Chua, P. Yao, and J. Akther Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma Pathol Oncol Res 15 2009 671 678
    • (2009) Pathol Oncol Res , vol.15 , pp. 671-678
    • Chua, T.C.1    Yao, P.2    Akther, J.3
  • 20
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
    • (2000) J Natl Cancer Inst , vol.92 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3
  • 21
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Soc 53 1958 457 481
    • (1958) J Am Stat Soc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 22
    • 0000336139 scopus 로고
    • Regression models and life tables (with discussion)
    • D.R. Cox Regression models and life tables (with discussion) J R Stat Soc B 34 1972 187 220
    • (1972) J R Stat Soc B , vol.34 , pp. 187-220
    • Cox, D.R.1
  • 23
    • 77956255022 scopus 로고    scopus 로고
    • Continued uncertainty regarding hyperthermic intraperitoneal chemotherapy in malignant peritoneal mesothelioma
    • M. Markman Continued uncertainty regarding hyperthermic intraperitoneal chemotherapy in malignant peritoneal mesothelioma J Clin Oncol 28 2010 e418
    • (2010) J Clin Oncol , vol.28 , pp. 418
    • Markman, M.1
  • 24
    • 84855830266 scopus 로고    scopus 로고
    • Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies
    • S. Kusamura, D. Baratti, and M. Deraco Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies Ann Surg 255 2012 348 356
    • (2012) Ann Surg , vol.255 , pp. 348-356
    • Kusamura, S.1    Baratti, D.2    Deraco, M.3
  • 25
    • 36248989049 scopus 로고    scopus 로고
    • Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma
    • N. Zaffaroni, A. Costa, and M. Pennati Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma Cell Oncol 29 2007 453 466
    • (2007) Cell Oncol , vol.29 , pp. 453-466
    • Zaffaroni, N.1    Costa, A.2    Pennati, M.3
  • 26
    • 18244362080 scopus 로고    scopus 로고
    • P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma
    • A.C. Borczuk, R.N. Taub, and M. Hesdorffer P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma Clin Cancer Res 11 2005 3303 3308
    • (2005) Clin Cancer Res , vol.11 , pp. 3303-3308
    • Borczuk, A.C.1    Taub, R.N.2    Hesdorffer, M.3
  • 27
    • 33646151164 scopus 로고    scopus 로고
    • Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation
    • K.L. Dumoff, C.S. Chu, and E.E. Harris Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation Mod Pathol 19 2006 708 716
    • (2006) Mod Pathol , vol.19 , pp. 708-716
    • Dumoff, K.L.1    Chu, C.S.2    Harris, E.E.3
  • 28
    • 59249105807 scopus 로고    scopus 로고
    • Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies
    • T. Ito, G. Ishii, and K. Nagai Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies Lung Cancer 63 2009 418 424
    • (2009) Lung Cancer , vol.63 , pp. 418-424
    • Ito, T.1    Ishii, G.2    Nagai, K.3
  • 29
    • 77950547974 scopus 로고    scopus 로고
    • Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas
    • J.P. Rodrigo, D. García-Carracedo, and M.V. González Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas Mol Cancer 9 2010 48
    • (2010) Mol Cancer , vol.9 , pp. 48
    • Rodrigo, J.P.1    García-Carracedo, D.2    González, M.V.3
  • 30
    • 84855357168 scopus 로고    scopus 로고
    • Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients
    • Y.K. Chao, W.Y. Chuang, and C.J. Yeh Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients J Surg Oncol 105 2012 183 188
    • (2012) J Surg Oncol , vol.105 , pp. 183-188
    • Chao, Y.K.1    Chuang, W.Y.2    Yeh, C.J.3
  • 31
    • 58549113827 scopus 로고    scopus 로고
    • Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma
    • J.M. Foster, Z. Gatalica, and S. Lilleberg Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma Ann Surg Oncol 16 2009 152 158
    • (2009) Ann Surg Oncol , vol.16 , pp. 152-158
    • Foster, J.M.1    Gatalica, Z.2    Lilleberg, S.3
  • 32
    • 77957203611 scopus 로고    scopus 로고
    • Receptor tyrosine kinase and downstream signaling analysis in diffuse malignant peritoneal mesothelioma
    • F. Perrone, G. Jocollè, and M. Pennati Receptor tyrosine kinase and downstream signaling analysis in diffuse malignant peritoneal mesothelioma Eur J Cancer 46 2010 2837 2848
    • (2010) Eur J Cancer , vol.46 , pp. 2837-2848
    • Perrone, F.1    Jocollè, G.2    Pennati, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.